NFKB1 and cancer: When one of the main regulators of inflammation—the transcription nuclear factor kappa B (NF-κB)—is constitutively activated due to translocation to the nucleus, the inflammation is no longer an acute, rapid protective reaction of the body to pathogens, but in itself is a stimulus for the development of serious pathologies, including cancer and autoimmune diseases [1].